Jan Sloves: 7 Key Insights That Predict Recovery After Venous Recanalization
Jan Sloves, President and Consultant at Vascular Imaging Professionals LLC, shared on LinkedIn:
”My 7 most impactful and relevant take-home points ‘Predictive Factors for Complete Recovery of Post-Thrombotic Syndrome 6 Months After Venous Recanalization,’ presented in a logical order.
1. Recanalization Benefits: Endovascular venous recanalization delivers substantial symptom relief for PTS, with approximately two-thirds of patients showing improvement at 6 months, especially for chronic iliofemoral obstruction.
2. Key Predictors of Poor Recovery: Higher baseline Villalta scores and coexistent femoral vein obstruction were the strongest predictors of persistent PTS after intervention; these factors can be easily identified before recanalization.
3. Development of a Practical Risk Score: A simple risk score – baseline Villalta score plus 4 points for femoral vein obstruction – helps stratify patients for their likelihood of full recovery, supporting more personalized counseling and management decisions.
4. Patency Outcomes: Primary and secondary stent patency rates at 6 months were 75% and 81%, respectively. Early stent occlusion and persistent femoral vein outflow obstruction are associated with continued symptoms and need for further intervention.
5. Essential Role of Compression Therapy: Graduated compression stockings remain a standard adjunct after recanalization and are recommended for all to support symptom improvement and maintain patency.
6. Safety of Dual Antithrombotic Regimens: Combining anticoagulation & antiplatelet therapy after procedure is both safe (very low bleeding risk) and may further support patency during the critical post-interventional healing window.
7. Structured Follow-up is Critical: Dedicated post-procedural clinical & duplex surveillance at 1 month, 6 months, and then annually is essential for detecting stent complications, recurrent obstruction, or persistent symptoms – enabling timely reintervention when needed.
Subscribe to the only newsletter built for vascular pros.”

Keep up with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia
